(Q37031574)

17 August 2017

1 reference

title

Guanfacine and guanfacine extended release: treatment for ADHD and related disorders (English)

1 reference

18078429

attention deficit hyperactivity disorder

17 August 2017

main subject

0 references

author name string

David J Posey

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494159&resulttype=core&format=json

14 May 2020

Christopher J McDougle

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494159&resulttype=core&format=json

14 May 2020

language of work or name

1 reference

1 January 2007

1 reference

18078429

CNS Neuroscience & Therapeutics

17 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494159&resulttype=core&format=json

14 May 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494159&resulttype=core&format=json

14 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494159&resulttype=core&format=json

14 May 2020

page(s)

465-474

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494159&resulttype=core&format=json

Clonidine treatment of Gilles de la Tourette's syndrome

14 May 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2007.00026.X

Neocortical system abnormalities in autism: an fMRI study of spatial working memory

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1527-3458.2007.00026.X

Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: A statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association

21 January 2018

1 reference

12 December 2020

Guanfacine and secondary mania in children

1 reference

12 December 2020

A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Hypertensive urgency induced by an interaction of mirtazapine and clonidine

1 reference

12 December 2020

The effects of an alpha-2 adrenergic agonist, guanfacine, on rCBF in human cortex in normal controls and subjects with focal epilepsy

1 reference

12 December 2020

Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey

1 reference

12 December 2020

Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder

1 reference

12 December 2020

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

1 reference

12 December 2020

Asperger syndrome: a proton magnetic resonance spectroscopy study of brain

1 reference

12 December 2020

Substituted phenylacetylguanidines: a new class of antihypertensive agents

1 reference

12 December 2020

A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children

1 reference

12 December 2020

Clonidine treatment of hyperactive and impulsive children with autistic disorder

1 reference

12 December 2020

Performance on Cambridge Neuropsychological Test Automated Battery subtests sensitive to frontal lobe function in people with autistic disorder: evidence from the Collaborative Programs of Excellence in Autism network.

1 reference

12 December 2020

Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases

1 reference

12 December 2020

A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism

1 reference

12 December 2020

Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions

1 reference

12 December 2020

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity

1 reference

12 December 2020

Antagonism of antihypertensive effect of guanfacine by tricyclic antidepressants

1 reference

12 December 2020

Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification

1 reference

12 December 2020

Guanfacine produces differential effects in frontal cortex compared with striatum: assessed by phMRI BOLD contrast

1 reference

12 December 2020

A prospective open trial of guanfacine in children with pervasive developmental disorders

1 reference

12 December 2020

The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD)

1 reference

12 December 2020

Parent and teacher ratings of attention-deficit/hyperactivity disorder symptoms: Factor structure and normative data

1 reference

12 December 2020

The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes.

1 reference

12 December 2020

Pre- and postsynaptic effects of α-agonists inthe anococcygeus muscle of the pithed rat

1 reference

12 December 2020

Pharmacokinetics of guanfacine in patients with impaired renal function and in some elderly patients

1 reference

12 December 2020

Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.

1 reference

12 December 2020

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

1 reference

12 December 2020

Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children

1 reference

12 December 2020

Rapid clonidine withdrawal with blood pressure overshoot exaggerated by beta-blockade

1 reference

12 December 2020

Normative data on revised Conners Parent and Teacher Rating Scales

1 reference

12 December 2020

Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience

1 reference

12 December 2020

An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Guanfacine as an alpha-2-agonist inducer of growth hormone secretion--a comparison with clonidine

1 reference

12 December 2020

Levodopa and levoamphetamine: a crossover study in young schizophrenic children

1 reference

12 December 2020

Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry

1 reference

12 December 2020

10.1111/J.1527-3458.2007.00026.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494159&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6494159&resulttype=core&format=json

14 May 2020

18078429

1 reference